PMID- 35807020 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230308 IS - 2077-0383 (Print) IS - 2077-0383 (Electronic) IS - 2077-0383 (Linking) VI - 11 IP - 13 DP - 2022 Jun 28 TI - One-Year Follow-Up of Patients Admitted for Emergency Coronary Angiography after Resuscitated Cardiac Arrest. LID - 10.3390/jcm11133738 [doi] LID - 3738 AB - (1) Background: Despite the improvement of the in-hospital survival rate after aborted sudden cardiac death (SCD), cerebral anoxia may have severe neurologic consequences and may impair long-term outcome and quality of life of surviving patients. The aim of this study was to assess neurological outcomes at one year after resuscitated cardiac arrest; (2) Methods: This prospective, observational, and multicentre study included patients >18 yo admitted in the catheterisation laboratory for coronary angiography after aborted SCD between 1 May 2018 and 31 May 2020. Only patients who were discharged alive from hospital were evaluated. The primary endpoint was survival without neurological sequelae at one-year follow-up defined by a cerebral performance category (CPC) of one or two. Secondary end points included all-cause mortality, New York Heart Association (NYHA) functional class, neurologic evaluation at discharge, three-month and one-year follow-up using the CPC scale, and quality of life at 1 year using the Quality of Life after Brain Injury (QOLIBRI) questionnaire; (3) Results: Among 143 patients admitted for SCD within the study period, 61 (42.7%) were discharged alive from hospital, among whom 55 (90.1%) completed the one-year follow-up. No flow and low flow times were 1.9 +/- 2.4 min and 16.5 +/- 10.4 min, respectively. For 93.4% of the surviving patients, an initial shockable rhythm (n = 57) was observed and acute coronary syndrome was diagnosed in 75.4% of them (n = 46). At 1 year, survival rate without neurologic sequelae was 87.2% (n = 48). Patients with poor outcome were older (69.3 vs. 57.4 yo; p = 0.04) and had lower body mass index (22.4 vs. 26.7; p = 0.013) and a lower initial Left Ventricle Ejection Fraction (LVEF) (32.1% vs. 40.3%; p = 0.046). During follow-up, neurological status improved in 36.8% of patients presenting sequelae at discharge, and overall quality of life was satisfying for 66.7% of patients according to the QOLIBRI questionnaire; (4) Conclusions: Among patients admitted to the catheterisation laboratory for aborted SCD, mainly related to Acute Coronary Syndrom (ACS), less than a half of them were alive at discharge. However, the one-year survival rate without neurological sequelae was high and overall quality of life was good. FAU - Delbaere, Quentin AU - Delbaere Q AD - Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France. FAU - Akodad, Myriam AU - Akodad M AD - Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France. FAU - Roubille, Francois AU - Roubille F AUID- ORCID: 0000-0002-5288-9687 AD - Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France. FAU - Lattuca, Benoit AU - Lattuca B AUID- ORCID: 0000-0001-6167-500X AD - Department of Cardiology, Caremeau University Hospital, 30900 Nimes, France. FAU - Cayla, Guillaume AU - Cayla G AD - Department of Cardiology, Caremeau University Hospital, 30900 Nimes, France. FAU - Leclercq, Florence AU - Leclercq F AUID- ORCID: 0000-0001-5936-5184 AD - Department of Cardiology, Arnaud de Villeneuve University Hospital, 34295 Montpellier, France. LA - eng PT - Journal Article DEP - 20220628 PL - Switzerland TA - J Clin Med JT - Journal of clinical medicine JID - 101606588 PMC - PMC9267145 OTO - NOTNLM OT - coronary angiography OT - neurological sequelae OT - quality of life OT - sudden cardiac death COIS- The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. EDAT- 2022/07/10 06:00 MHDA- 2022/07/10 06:01 PMCR- 2022/06/28 CRDT- 2022/07/09 01:16 PHST- 2022/05/17 00:00 [received] PHST- 2022/06/15 00:00 [revised] PHST- 2022/06/17 00:00 [accepted] PHST- 2022/07/09 01:16 [entrez] PHST- 2022/07/10 06:00 [pubmed] PHST- 2022/07/10 06:01 [medline] PHST- 2022/06/28 00:00 [pmc-release] AID - jcm11133738 [pii] AID - jcm-11-03738 [pii] AID - 10.3390/jcm11133738 [doi] PST - epublish SO - J Clin Med. 2022 Jun 28;11(13):3738. doi: 10.3390/jcm11133738.